I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 41 350 VND -0.12% Market Closed
Market Cap: 6.4T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Interest Income Expense
â‚«7.3B
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
-5%
H
HaTay Pharmaceutical JSC
VN:DHT
Interest Income Expense
â‚«3.6B
CAGR 3-Years
-36%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
C
Cuu Long Pharmaceutical JSC
VN:DCL
Interest Income Expense
â‚«6.4B
CAGR 3-Years
-45%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Interest Income Expense
â‚«34B
CAGR 3-Years
68%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Interest Income Expense
â‚«131.4B
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
14%
T
Traphaco JSC
VN:TRA
Interest Income Expense
â‚«23.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Imexpharm Corp
Glance View

Market Cap
6.4T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
27 964.22 VND
Overvaluation 32%
Intrinsic Value
Price
I

See Also

What is Imexpharm Corp's Interest Income Expense?
Interest Income Expense
7.3B VND

Based on the financial report for Sep 30, 2024, Imexpharm Corp's Interest Income Expense amounts to 7.3B VND.

What is Imexpharm Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-5%

Over the last year, the Interest Income Expense growth was -62%. The average annual Interest Income Expense growth rates for Imexpharm Corp have been 5% over the past three years , -16% over the past five years , and -5% over the past ten years .

Back to Top